Search results

Page title matches

Fibrate
...or=Barter PJ, Rye KA| title=Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism? | journal=Circulation | year= 2006 | volum A narrative review concluded that "the benefit of adding a fibrate to statin therapy in reducing the risk of cardiovascular events in patient

4 KB (480 words) - 03:50, 26 April 2012
Fibrate/Definition

111 bytes (11 words) - 14:35, 3 November 2009
Fibrate/Related Articles

343 bytes (37 words) - 14:39, 3 November 2009

Fibrate
...or=Barter PJ, Rye KA| title=Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism? | journal=Circulation | year= 2006 | volum A narrative review concluded that "the benefit of adding a fibrate to statin therapy in reducing the risk of cardiovascular events in patient

4 KB (480 words) - 03:50, 26 April 2012
Gemfibrozil
...ide]] levels, with variable effects on [[cholesterol]]. Gemfibrozil is a [[fibrate]] derivative similar to [[bezafibrate]], [[clofibrate]], and [[procetofen]]

2 KB (208 words) - 09:09, 3 November 2009
Antilipemic agent
...Schelleman H, Bilker WB, Brensinger CM, Wan F, Yang YX, Hennessy S| title=Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. |

2 KB (227 words) - 07:30, 11 May 2010
Anticholesteremic agent
[[Fibrate]]s (fibric acid derivatives)

3 KB (339 words) - 09:11, 24 February 2010
Cytochrome P-450
...=Schelleman H, Bilker WB, Brensinger CM, Wan F, Yang YX, Hennessy S| title=Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. | j ...Schelleman H, Bilker WB, Brensinger CM, Wan F, Yang YX, Hennessy S| title=Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. |

22 KB (2,960 words) - 17:35, 10 February 2024
Warfarin
...me="pmid20103024">{{cite journal| author=Schelleman H ''et al.'' | title=Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. |

52 KB (7,136 words) - 22:53, 6 April 2014